NAB 365的支气管扩张作用。
The bronchodilator effect of NAB 365.
作者信息
Kamburoff P L, Prime F J, Schmidt O P
出版信息
Br J Clin Pharmacol. 1977 Feb;4(1):67-71. doi: 10.1111/j.1365-2125.1977.tb00669.x.
Abstract
- Dose response relationships for salbutamol and a new bronchodilator drug NAB 365 have been obtained in patients with reversible airways obstruction. These show that the latter is about one hundred times more potent than the former. 2. NAB 365 has a very long half-life. The implications of this are discussed.
摘要
- 已在可逆性气道阻塞患者中获得了沙丁胺醇和一种新型支气管扩张剂NAB 365的剂量反应关系。这些结果表明，后者的效力约为前者的一百倍。2. NAB 365具有很长的半衰期。本文讨论了其意义。
相似文献
1
The bronchodilator effect of NAB 365.NAB 365的支气管扩张作用。
Br J Clin Pharmacol. 1977 Feb;4(1):67-71. doi: 10.1111/j.1365-2125.1977.tb00669.x.
2
Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
Br J Dis Chest. 1980 Jan;74(1):70-7.
3
A comparison of oral procaterol and albuterol in reversible airflow obstruction.口服丙卡特罗与沙丁胺醇治疗可逆性气流受限的比较。
Am Rev Respir Dis. 1988 Dec;138(6):1504-9. doi: 10.1164/ajrccm/138.6.1504.
4
Proceedings: Comparison of two bronchodilators--salmefamol and salbutamol.会议论文：两种支气管扩张剂——沙美特罗和沙丁胺醇的比较。
Tubercle. 1975 Jun;56(2):171. doi: 10.1016/0041-3879(75)90046-x.
5
Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma.
Ann Allergy. 1992 Mar;68(3):267-73.
6
NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial.NAB 365（克仑特罗）与沙丁胺醇治疗哮喘患者的双盲临床试验
Int J Clin Pharmacol Biopharm. 1979 Apr;17(4):176-80.
7
Comparison of salmefamol and salbutamol in patients with chronic airways obstruction.沙美特罗与沙丁胺醇对慢性气道阻塞患者疗效的比较。
Br J Clin Pharmacol. 1976 Feb;3(1):151-5. doi: 10.1111/j.1365-2125.1976.tb00582.x.
8
Double-blind trial with increasing doses of salbutamol and terbutaline aerosols in patients with reversible airways obstruction.对可逆性气道阻塞患者使用递增剂量沙丁胺醇和特布他林气雾剂的双盲试验。
Acta Med Scand. 1972 Nov;192(5):371-6. doi: 10.1111/j.0954-6820.1972.tb04832.x.
9
A comparative study of atropine methonitrate, salbutamol, and their combination in airways obstruction.硝酸甲阿托品、沙丁胺醇及其联合用药治疗气道阻塞的对比研究
Thorax. 1979 Feb;34(1):45-50. doi: 10.1136/thx.34.1.45.
10
An economical method of comparing inhaled bronchodilators in reversible diffuse airways obstruction. With special reference to a beta-2 stimulant--salmefamol.一种用于比较可逆性弥漫性气道阻塞中吸入性支气管扩张剂的经济方法。特别提及一种β-2兴奋剂——沙美特罗。
Thorax. 1974 May;29(3):317-22. doi: 10.1136/thx.29.3.317.
引用本文的文献
1
Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.哮喘和 COPD：聚焦β-激动剂——过去、现在和未来。
Handb Exp Pharmacol. 2024;285:369-451. doi: 10.1007/164_2023_679.
2
Cardiac, pulmonary and neuromuscular effects of clenbuterol and terbutaline compared with placebo.与安慰剂相比，克仑特罗和特布他林对心脏、肺部及神经肌肉的影响。
Br J Clin Pharmacol. 1981 Aug;12(2):195-200. doi: 10.1111/j.1365-2125.1981.tb01200.x.
3
Dose response relationship of clenbuterol (NAB 365) as a solution for inhalation.盐酸克伦特罗（NAB 365）吸入溶液的剂量反应关系。
Eur J Clin Pharmacol. 1979 Apr 17;15(3):159-62. doi: 10.1007/BF00563099.
4
Study of a new oral beta-adrenergic drug, clenbuterol, in patients with chronic bronchitis.新型口服β-肾上腺素能药物克仑特罗治疗慢性支气管炎患者的研究。
Eur J Clin Pharmacol. 1978 May 31;13(3):171-7. doi: 10.1007/BF00609979.
5
A trial of clenbuterol in bronchial asthma.克仑特罗治疗支气管哮喘的试验。
Thorax. 1977 Dec;32(6):717-9. doi: 10.1136/thx.32.6.717.
本文引用的文献
1
A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease.一种使用体容积描记器测量人体气道阻力的新方法：正常受试者和呼吸系统疾病患者的测量值。
J Clin Invest. 1956 Mar;35(3):327-35. doi: 10.1172/JCI103282.
2
[Pulmonary function tests using the broncholytic agent NAB 365].
Med Monatsschr. 1972 Jul;26(7):325-8.
3
[Structure activity relationship in a series of new amino-halogen substituted phenyl-aminoethanols].
Arzneimittelforschung. 1972 May;22(5):869-76.
4
[The clinical pharmacology of a new specific adrenergic beta bronchodilator].
Int J Clin Pharmacol. 1974 Jun;9(4):305-13.
Zotero 插件